Bavarian Nordic A/S
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an or… Read more
Bavarian Nordic A/S (BVNKF) - Total Assets
Latest total assets as of September 2025: $15.16 Billion USD
Based on the latest financial reports, Bavarian Nordic A/S (BVNKF) holds total assets worth $15.16 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bavarian Nordic A/S - Total Assets Trend (2001–2024)
This chart illustrates how Bavarian Nordic A/S’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bavarian Nordic A/S - Asset Composition Analysis
Current Asset Composition (December 2024)
Bavarian Nordic A/S's total assets of $15.16 Billion consist of 40.2% current assets and 59.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.3% |
| Accounts Receivable | $1.18 Billion | 8.2% |
| Inventory | $2.33 Billion | 16.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $6.33 Billion | 44.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how Bavarian Nordic A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bavarian Nordic A/S's current assets represent 40.2% of total assets in 2024, a decrease from 84.8% in 2001.
- Cash Position: Cash and equivalents constituted 11.3% of total assets in 2024, down from 43.8% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is intangible assets at 44.0% of total assets.
Bavarian Nordic A/S Competitors by Total Assets
Key competitors of Bavarian Nordic A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Bavarian Nordic A/S - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Bavarian Nordic A/S generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Bavarian Nordic A/S generates $6.86 in net profit.
Bavarian Nordic A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.84 | 1.69 | 2.50 |
| Quick Ratio | 2.43 | 0.98 | 1.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.09 Billion | $ 2.11 Billion | $ 1.43 Billion |
Bavarian Nordic A/S - Advanced Valuation Insights
This section examines the relationship between Bavarian Nordic A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.16 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | $14.41 Billion |
| Market Capitalization | $1.62 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bavarian Nordic A/S's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bavarian Nordic A/S's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bavarian Nordic A/S (2001–2024)
The table below shows the annual total assets of Bavarian Nordic A/S from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $14.41 Billion | +0.37% |
| 2023-12-31 | $14.35 Billion | +15.83% |
| 2022-12-31 | $12.39 Billion | +2.50% |
| 2021-12-31 | $12.09 Billion | +38.02% |
| 2020-12-31 | $8.76 Billion | +24.29% |
| 2019-12-31 | $7.05 Billion | +130.23% |
| 2018-12-31 | $3.06 Billion | -2.91% |
| 2017-12-31 | $3.15 Billion | +11.65% |
| 2016-12-31 | $2.82 Billion | +41.95% |
| 2015-12-31 | $1.99 Billion | +5.40% |
| 2014-12-31 | $1.89 Billion | +29.96% |
| 2013-12-31 | $1.45 Billion | -5.65% |
| 2012-12-31 | $1.54 Billion | -22.13% |
| 2011-12-31 | $1.98 Billion | +34.72% |
| 2010-12-31 | $1.47 Billion | +15.42% |
| 2009-12-31 | $1.27 Billion | -24.98% |
| 2008-12-31 | $1.69 Billion | -2.18% |
| 2007-12-31 | $1.73 Billion | +81.48% |
| 2006-12-31 | $954.42 Million | +2.78% |
| 2005-12-31 | $928.56 Million | +54.22% |
| 2004-12-31 | $602.10 Million | +40.29% |
| 2003-12-31 | $429.17 Million | +35.09% |
| 2002-12-31 | $317.70 Million | +413.46% |
| 2001-12-31 | $61.87 Million | -- |